Background. Recent evidence suggests that endothelial cell adhesion molecules may participate in the initiation and progression of atherosclerotic vascular damage. The aim of the present report was to investigate serum intercellular adhesion molecule-1 (ICAM-1), vascular cell adhesion molecule-1 (VCAM-1) and Eselectin concentrations and their probable association with atherosclerotic disease in patients on continuous ambulatory peritoneal dialysis (CAPD). Methods. Sixty-three CAPD patients and 40 age-and sex-matched apparently healthy normotensive controls participated in the study. Atherosclerotic disease in both groups was assessed by measuring the intimamedia thickness (IMT) and plaque score of the common carotid arteries using an ultrasound scanner. Results. Compared with controls, CAPD patients had significantly increased IMT and plaque score values (P<0.001 and P<0.0001, respectively), as well as serum ICAM-1, VCAM-1 and E-selectin concentrations (P<0.0001, P<0.0001 and P<0.05, respectively). In univariate analyses, IMT values were significantly correlated with age, systolic blood pressure (BP), logCRP, fibrinogen, albumin and ICAM-1 levels (P ¼ 0.001, P ¼ 0.04, P ¼ 0.01, P ¼ 0.04, P ¼ 0.02 and P ¼ 0.002, respectively). Multivariate analysis showed that ICAM-1 levels were a strong independent correlate of IMT (P ¼ 0.005). Serum albumin also remained independently associated with IMT values (P ¼ 0.03).
Introduction
The morbidity and mortality from atherosclerotic cardiovascular disease (AVD) is greatly increased in patients with end-stage renal disease (ESRD) undergoing renal replacement therapy [1] [2] [3] . The higher prevalence of several traditional and uraemia-related risk factors for atherogenesis, such as hypertension, hyperlipidaemia, diabetes mellitus, haemodynamic overload, anaemia and increased oxidative stress cannot fully explain this increased burden of AVD, indicating that other factors, yet to be defined, are also likely to be triggered in this patient population [1, 2] . Several recent studies have reported a particularly strong association between atherosclerosis and chronic inflammation, as defined by elevated C-reactive protein (CRP) and other acute phase proteins, in ESRD patients [4] [5] [6] . In addition, emerging evidence suggests an important role for endothelial cell adhesion molecules in the initiation and progression of atherosclerosis through their effects on leukocyte activation, cell migration and smooth muscle cell proliferation. Adhesion molecules intercellular adhesion molecule-1 (ICAM-1), vascular cell adhesion molecule-1 (VCAM-1) and E-selectin, expressed on the surface of vascular endothelial cells in response to proinflammatory cytokines, have been detected by immunohistochemistry in human atherosclerotic lesions, and their expression was found to be correlated with intimal infiltration by T lymphocytes and monocytes/macrophages [7] . Moreover, there are some reports indicating that circulating levels of adhesion molecules may serve as indirect markers for atherosclerotic vascular damage [8] . We have previously demonstrated that endothelial adhesion molecules are increased in chronic haemodialysis (HD) patients and are associated with markers of inflammation and carotid atherosclerosis [6] . Since studies in the restricted population of ESRD patients on continuous ambulatory peritoneal dialysis (CAPD) are limited, we undertook an investigation of circulating endothelial adhesion molecule levels in stable CAPD patients and their probable association with atherosclerotic disease as assessed by high-resolution ultrasonography of the common carotid arteries.
Subjects and methods

Subjects
Between March and April 2002, 63 adult patients on CAPD (27 male, mean age 67 years, range 19-86 years) from the Peritoneal Dialysis Unit of the University Department of Nephrology at Hippokration General Hospital consecutively entered the study. All patients had been on CAPD for more than 3 months (mean CAPD duration 42 months, range 6-147 months) and were clinically stable and free of active infection. Chronic renal failure was attributed to diabetic nephropathy in 19 cases, glomerulonephritis in 16 cases, tubulointerstitial nephritis in 12 cases, polycystic kidney disease in four cases, renovascular hypertension in four cases and was undetermined in eight cases. Patients with liver disease, autoimmune diseases or malignancies were excluded, in order to avoid the possible effects of these comorbid conditions on cytokine production. None of the patients was receiving antibiotics, corticosteroids or cytotoxic drugs at the time of the study. All patients were on a four to five exchanges per day schedule with standard dialysis bags. Forty-seven patients (74.6%) were receiving one or more antihypertensive drugs (calcium channel blockers, angiotensin-converting enzyme inhibitors, angiotensin II receptor antagonists, oral nitrates or betablockers) at the time of the study. Forty-nine patients (77.8%) were on recombinant human erythropoietin therapy and the mean dosage was 52±27 IU/kg body weight/week. Thirtythree patients (52.4%) had a past history of cardiovascular events (CVE). Of the 33 patients, 19 had a history of myocardial infarction, coronary artery bypass or angina with abnormal coronarography or myocardial scintigraphy, five had suffered from stroke and nine had abdominal aortic or lower extremity arterial disease. The control group consisted of 40 age-and sex-matched apparently healthy subjects (17 male, mean age 65 years, range 22-85 years) who were recruited from hospital staff members and their relatives. These control subjects did not have any history of hypertension, diabetes mellitus and renal or vascular disease, and were receiving no drugs at the time of the study. The study protocol conformed to the ethical guidelines of our institution and an informed consent was obtained from each participant.
Blood pressure measurements
In CAPD patients, the average blood pressure (BP) was calculated on the basis of a series of 10-20 measurements taken at home during the month preceding the study. Average home BP was reported to be closely related to 24 h ambulatory arterial pressure and satisfactory reflect the pressor burden of the cardiovascular system in these patients [9] . In control subjects, BP was measured after 15 min of recumbency and five measurements 2 min apart were averaged.
Laboratory methods
Blood samples from CAPD patients and control subjects were taken from a peripheral vein under fasting conditions. Serum samples were separated from clotted blood by immediate centrifugation (1500 g for 10 min), aliquoted and stored at À70 C until assay. Serum levels of the circulating adhesion molecules ICAM-1, VCAM-1 and E-selectin were measured by an enzyme-linked immunosorbent assay using commercially available standard kits (Quantikine human sICAM-1, sVCAM-1 and sE-selectin; Research and Diagnostic Systems Europe Ltd, Abington, UK) as previously described [6] . Haemoglobulin, fibrinogen, serum albumin, total cholesterol, triglycerides and HDL-cholesterol measurements were carried out by using standard methods in the routine clinical laboratory. For CAPD patients, monthly serum albumin concentration was averaged for the 6 months preceding the study start date. The mean value for serum albumin was then obtained for each patient and was considered for statistical assessment. LDL-cholesterol was calculated using the Friedewald formula. Serum CRP levels were evaluated by high sensitivity nephelometry and exact CRP values were obtained in all patients.
Carotid ultrasonography
Ultrasonographic studies were performed with a Aloka Sonos SSD-1700 (Aloka, Tokyo, Japan) instrument using a 7.5 MHz high-resolution probe. Each subject was examined in the supine position in a semi-dark room. The ultrasonographic study was performed within 1 week after blood sampling and on an empty abdomen in CAPD patients. The carotid artery was investigated bilaterally by the same expert radiologist (M.K.) who was unaware of clinical and laboratory data. Intima-media thickness (IMT) was defined as a low-level echo grey band that does not project into the arterial lumen and was measured at the diastolic phase as the distance between the leading edge of the first and second echogenic line. IMT was measured on the longitudinal views of the far wall of the distal segment of common carotid artery, the carotid bifurcation, and the initial tract of the internal carotid artery on both sides. Measurements were performed 0.5, 1 and 2 cm below and above the bifurcation (six measurements on each side) in a plaque-free arterial segment. The average measurement of the obtained values was taken as IMT and it was considered abnormal when it exceeded 0.82 mm [10] . Carotid plaques were defined (and counted) either as faint grey echoes (soft plaques) or bright white echoes (calcified plaques) protruding into the arterial lumen. Plaque thickness was measured in a suitable longitudinal or transverse view. Plaque score was computed by summing maximum thickness in millimetres of plaques in each segment on both sides.
Statistical analysis
Data are expressed as means±SD. The significance of differences in means between the two groups was assessed by Student's t-test or the Mann-Whitney test as appropriate. Differences in proportions were tested with the use of the chi-square statistic. Correlations were tested by regression analysis. Not-normally distributed variables were logtransformed before entering regression analysis. Multiple regression analysis with a forward elimination procedure was used to assess the combined influence of variables on IMT and plaque score values. The following variables were used: age, sex, smoking, CAPD duration, history of CVE, diabetes mellitus, systolic and diastolic BP, serum albumin, cholesterol, triglycerides, HDL, LDL, fibrinogen, logCRP, ICAM-1, VCAM-1 and E-selectin levels. The calculations were performed using Statview v. 4.5 statistical software (Abacus Concept Inc., Berkeley, CA, USA). A two-tailed Pvalue of <0.05 was considered to be statistically significant.
Results
The somatometric, haemodynamic and biochemical characteristics as well as the risk factors for atherosclerosis of controls and CAPD patients are shown in Table 1 . Triglycerides were significantly increased and HDL-cholesterol was significantly decreased in CAPD patients compared with control subjects. In addition, systolic BP was elevated in CAPD patients whereas diastolic BP did not differ significantly between the two groups (Table 1) .
CAPD patients had a significantly increased IMT and plaque score compared with control subjects (0.89±0.13 vs 0.71±0.08 mm, P<0.001 and 9.30± 5.43 vs 0.54±0.83 mm, P<0.0001, respectively). IMT was increased (>0.82 mm) in 41 (65.1%) of the CAPD patients. Atherosclerotic plaques were detected in 60 (95.2%) of the CAPD patients and in 11 (27.5%) of the controls. The difference in plaque occurrence between the two groups was significant (P<0.001).
Ultrasonographic findings and risk factors for atherosclerosis
respectively). In CAPD patients, plaque score was also significantly correlated with systolic BP (r ¼ 0.26, P ¼ 0.04). Ultrasonographic parameters did not show any significant correlation with other classic cardiovascular risk factors in both groups, such as gender, smoking status, total cholesterol, triglycerides, HDL-and LDL-cholesterol or CAPD duration, diabetes mellitus and history of CVE in CAPD patients.
Ultrasonographic findings, inflammation and malnutrition
Compared with controls, CAPD patients had significantly increased CRP and fibrinogen values (3.8±0.8 vs 12.9±13.9 mg/l, P<0.0001 and 2.68±0.70 vs 5.44± 1.14 g/l, P<0.0001, respectively) ( Table 1 ). Thirty-nine CAPD patients (61.9%) had abnormal CRP (normal <5 mg/l) and 60 patients (95.2%) had increased fibrinogen levels (normal range 2-4 g/l). Fibrinogen values were significantly correlated with logCRP (r ¼ 0.38, P ¼ 0.002). In univariate analyses, IMT, but not plaque score, values were significantly correlated with log-transformed CRP (r ¼ 0.32, P ¼ 0.01 and r ¼ 0.14, P ¼ NS, respectively). Fibrinogen levels were significantly correlated with both IMT and plaque score values (r ¼ 0.26, P ¼ 0.04 and r ¼ 0.34, P ¼ 0.01, respectively) ( Figure 1 ). Multivariate analysis showed that fibrinogen values were a strong independent correlate of plaque score (r ¼ 39, P ¼ 0.002) ( Table 2) .
Mean 6 month serum albumin concentration was significantly decreased in CAPD patients compared with control subjects (3.63±0.43 vs 4.78±0.55 g/dl, P<0.0001) ( Table 1) . In univariate analyses, IMT, but not plaque score, values had a significant inverse correlation with albumin concentrations (r ¼ À0.28, P ¼ 0.02) (Figure 2, top) . Multivariate analysis showed that serum albumin was an independent contributor to IMT values (Table 3 ). In addition, compared with 
Ultrasonographic findings and endothelial adhesion molecules
Compared with control subjects, CAPD patients had significantly increased ICAM-1, VCAM-1 and Eselectin levels (234±73 vs 599±273 ng/ml, P<0.0001, 941±149 vs 2024±780 ng/ml, P<0.0001 and 62±32 vs 81±43 ng/ml, P<0.05, respectively). No significant differences were observed in adhesion molecule levels between diabetic and non-diabetic patients. In addition, adhesion molecule levels did not show any relation with age, gender or CAPD duration. However, ICAM-1 and VCAM-1, but not E-selectin, levels were significantly correlated with logCRP values (r ¼ 0.31, P ¼ 0.01 and r ¼ 0.27, P ¼ 0.03, respectively). Serum levels of ICAM-1, but not VCAM-1 or Eselectin, were significantly correlated with IMT (r ¼ 0.39, P ¼ 0.002) (Figure 2, bottom) . Moreover, compared with patients with normal IMT, patients with increased IMT values (>0.82 mm) had significantly elevated ICAM-1 (494±208 vs 655±289 ng/ml, P<0.05). Multivariate analysis showed that serum ICAM-1 levels were a strong independent correlate of IMT (r ¼ 0.36, P ¼ 0.005) ( Table 3 ). When ICAM-1 was excluded from the model, the independent variables linked to IMT values were age, serum albumin and fibrinogen (r ¼ 0.39, P ¼ 0.001, r ¼ À0.33, P ¼ 0.01 and r ¼ 0.26, P ¼ 0.04, respectively). Adhesion molecule concentrations failed to be significant contributors to the plaque score either on univariate or multivariate analyses.
Discussion
Recently, atherosclerotic disease has been regarded as an inflammatory disorder and several studies have reported a strong association between chronic inflammation, as defined by increased CRP levels and atherosclerosis in ESRD patients both on conservative treatment and on maintenance HD [4] [5] [6] . However, the value of CRP as a marker of atherosclerotic vascular damage is less well known in the restricted population of ESRD patients on CAPD. In the present study, a significant association was observed between CRP and IMT values but the former failed to be an independent correlate of carotid atherosclerotic changes in multivariate analysis.
Fibrinogen is a principal coagulation protein as well as an acute phase reactant and is recently considered to be atherogenic. Fibrinogen levels have been reported to be increased and associated with vascular disease and an increased risk of death in ESRD patients [11] [12] [13] . In univariate analysis, IMT values were significantly correlated with fibrinogen concentrations, whereas in multivariate analysis the latter was independently associated with IMT if serum ICAM-1 was not included in the model. Moreover, fibrinogen levels were significantly associated with plaque score values both on univariate and multivariate analyses. Overall, the above findings, which have not been previously reported, indicate that, at least in CAPD patients, fibrinogen concentrations are a valuable surrogate marker for atherosclerotic vascular damage. In addition, based on these results it could be speculated that the hypercoagulable state produced by high fibrinogen levels has an important role in the advanced stages of atherosclerosis characterized by the development of plaques and obstructive lesions.
In recent years, several studies in ESRD patients have shown an association between signs of malnutrition and particularly low serum albumin and increased morbidity and mortality [14] [15] [16] [17] . However, some reports in HD patients have demonstrated that the activity of the acute phase response is an important predictor of low serum albumin, suggesting that malnutrition and atherosclerosis could be interlinked by inflammation [18, 19] . The present study showed a significant and inverse correlation of IMT values with serum albumin levels both on univariate and multivariate analyses. Furthermore, this relationship appeared minimally influenced by other covariates including inflammatory markers. The above results support the concept that hypoalbuminaemia per se may also accelerate atherosclerosis, although the biological basis of this association remains to be elucidated.
Compared with controls, CAPD patients had significantly increased serum ICAM-1, VCAM-1 and Eselectin levels and these results concur with a previous report in a small number of patients [20] . Moreover, significant correlations were observed between CRP and adhesion molecule ICAM-1 and VCAM-1 levels suggesting that inflammation may be a major cause of elevated serum levels of these proteins in CAPD patients. Interestingly, and in accordance with our previous report in HD patients [6] , a highly significant association was observed between carotid IMT, but not plaque score values, and serum ICAM-1 levels. Multivariate analysis showed that ICAM-1 levels were a strong independent correlate of IMT, whereas serum albumin and fibrinogen became significant correlates of IMT values only when ICAM-1 levels were excluded from the analysis. Furthermore, this association appeared relatively independent from a number of traditional or uraemia-related risk factors for atheroscerosis. The above data indicate that ICAM-1 is a valuable molecular marker of early atherosclerotic changes, integrating information otherwise present in a number of other less strongly related variables, including other markers of inflammation. Moreover, based on the above results, it is tempting to speculate that this correlation implies a pathogenic role for ICAM-1 on the early events of the atherosclerotic process leading to diffuse intimal thickening. However, clearly, additional studies are necessary to confirm the above intriguing hypothesis.
In conclusion, in CAPD patients, carotid atherosclerosis is associated with markers of inflammation and malnutrition and circulating levels of adhesion molecule ICAM-1. Hypoalbuminaemia and serum ICAM-1 appeared independently correlated with atherogenesis, although the mechanisms supporting these associations remain to be identified. Larger additional studies are needed to investigate the potential value of ICAM-1 levels for cardiovascular risk stratification in chronic renal failure patients.
